Immediate Impact
1 standout
Citing Papers
Potential therapeutic options for COVID-19: an update on current evidence
2022 Standout
Works of Varun Bafna being referenced
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Varun Bafna | 25 | 3 | 3 | 6 | 5 | 4 | 27 | |
| María Castillo de la Osa | 24 | 2 | 3 | 8 | 7 | 3 | 31 | |
| Naya Faro‐Míguez | 21 | 4 | 2 | 14 | 4 | 6 | 28 | |
| Marisa Di Natale | 13 | 3 | 1 | 10 | 8 | 4 | 26 | |
| Kaitlin A. Stromberg | 19 | 2 | 8 | 7 | 4 | 28 | ||
| Linda M. Wrijil | 19 | 1 | 5 | 5 | 5 | 4 | 35 | |
| Déborah Eshagh | 13 | 5 | 2 | 4 | 7 | 3 | 30 | |
| Andrea Morrison-Porter | 24 | 2 | 6 | 2 | 2 | 29 | ||
| Gorana Vukorepa | 13 | 4 | 2 | 4 | 9 | 4 | 21 | |
| Mikhail Gilyarov | 19 | 3 | 15 | 2 | 2 | 34 | ||
| Federica Farolfi | 14 | 2 | 2 | 11 | 4 | 2 | 21 |
All Works
Loading papers...